Related Experiment Video
Updated: Dec 4, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Contribution of miRNAs, tRNAs and tRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer
Ilias Skeparnias1, Dimitrios Anastasakis1,2, Katerina Grafanaki1,3
1Department of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
Abstract:
Transcriptomics profiles of miRNAs, tRNAs or tRFs are used as biomarkers, after separate examination of several cancer cell lines, blood samples or biopsies. However, the possible contribution of all three profiles on oncogenic signaling and translation as a net regulatory effect, is under investigation. The present analysis of miRNAs and tRFs from lung cancer biopsies indicated putative targets, which belong to gene networks involved in cell proliferation, transcription and translation regulation. In addition, we observed differential expression of specific tRNAs along with several tRNA-related genes with possible involvement in carcinogenesis. Transfection of lung adenocarcinoma cells with two identified tRFs and subsequent NGS analysis indicated gene targets that mediate signaling and translation regulation. Broader analysis of all major signaling and translation factors in several biopsy specimens revealed a crosstalk between the PI3K/AKT and MAPK pathways and downstream activation of eIF4E and eEF2. Subsequent polysome profile analysis and 48S pre-initiation reconstitution experiments showed increased global translation rates and indicated that aberrant expression patterns of translation initiation factors could contribute to elevated protein synthesis. Overall, our results outline the modulatory effects that possibly correlate the expression of important regulatory non-coding RNAs with aberrant signaling and translation deregulation in lung cancer.
Insights
This study reveals how microRNAs (miRNAs) and tRNA-derived fragments (tRFs) in lung cancer influence oncogenic signaling and protein translation. Aberrant expression of these non-coding RNAs correlates with altered signaling pathways and increased protein synthesis in cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genomics
Background:
- MicroRNAs (miRNAs), transfer RNAs (tRNAs), and tRNA-derived fragments (tRFs) are investigated as potential cancer biomarkers.
- The combined regulatory effect of these non-coding RNAs on oncogenic signaling and translation remains understudied.
Purpose of the Study:
- To investigate the role of miRNAs and tRFs in lung cancer by analyzing their targets in gene networks.
- To explore the differential expression of tRNAs and related genes in lung carcinogenesis.
- To elucidate the impact of specific tRFs on signaling and translation pathways in lung adenocarcinoma cells.
Main Methods:
- Analysis of miRNA and tRF expression profiles in lung cancer biopsies.
- Next-generation sequencing (NGS) after transfection of lung adenocarcinoma cells with identified tRFs.
- Examination of signaling pathways (PI3K/AKT, MAPK) and translation factors (eIF4E, eEF2) in biopsy specimens.
- Polysome profiling and 48S pre-initiation complex reconstitution experiments.
Main Results:
- miRNAs and tRFs target gene networks involved in cell proliferation, transcription, and translation regulation.
- Differential expression of tRNAs and tRNA-related genes suggests their involvement in lung carcinogenesis.
- Transfection with tRFs identified targets mediating signaling and translation.
- Crosstalk between PI3K/AKT and MAPK pathways, with downstream activation of eIF4E and eEF2, was observed.
- Increased global translation rates and aberrant expression of translation initiation factors indicate elevated protein synthesis.
Conclusions:
- Regulatory non-coding RNAs, including miRNAs and tRFs, modulate signaling and translation pathways in lung cancer.
- Aberrant expression patterns of these RNAs correlate with deregulation of signaling and translation, contributing to tumorigenesis.
- These findings highlight the potential of miRNAs and tRFs as therapeutic targets in lung cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Regulation of Expression at Multiple Steps

